Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It offers Brilacidin, a immunomodulatory drug candidate with anti-inflammatory and antimicrobial therapeutic applications. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
Frequently asked questions
What sector does Innovation Pharmaceuticals Inc (IPIX) operate in?
Innovation Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Innovation Pharmaceuticals Inc (IPIX) current stock price?
As of the latest data, Innovation Pharmaceuticals Inc stock price is $0.00, with a previous close of $0.00. Innovation Pharmaceuticals Inc gained $0.00 in the last trading session, representing a 40% increase.
What is Innovation Pharmaceuticals Inc (IPIX) current market capitalization?
Innovation Pharmaceuticals Inc market cap is approximately 359.81 thousand.
What is Innovation Pharmaceuticals Inc (IPIX) Earnings Per Share (EPS)?
The trailing EPS is -$0.03.
Does Innovation Pharmaceuticals Inc (IPIX) pay dividends?
No. Innovation Pharmaceuticals Inc does not pay a dividend.
What is Innovation Pharmaceuticals Inc (IPIX) beta (volatility) score?
Innovation Pharmaceuticals Inc has a beta of 140.111, indicating very high volatility compared to the market.